title: Mitral, aortic and tricuspid valvular heart disease associated with ergotamine therapy for migraine.
authors.forename: A
authors.initials: A
authors.lastname: Wilke
authors.forename: H
authors.initials: H
authors.lastname: Hesse
authors.forename: G
authors.initials: G
authors.lastname: Hufnagel
authors.forename: B
authors.initials: B
authors.lastname: Maisch
mesh_terms: D001021:Aortic Valve / Q000187:drug effects; D004878:Ergotamine / Q000008:administration & dosage / Q000009:adverse effects*; D004881:Ergotism / Q000175:diagnosis*; D005260:Female; D006333:Heart Failure / Q000139:chemically induced; D006349:Heart Valve Diseases / Q000139:chemically induced* / Q000175:diagnosis; D006801:Humans; D008875:Middle Aged; D008881:Migraine Disorders / Q000188:drug therapy*; D008943:Mitral Valve / Q000187:drug effects; D014261:Tricuspid Valve / Q000187:drug effects
chemical_list: D004878:Ergotamine